Kate Therapeutics
San Diego
About Kate Therapeutics
Kate Therapeutics is a biotechnology company focused on developing adeno-associated virus (AAV)-based gene therapies targeting genetically defined muscle and heart diseases. The company utilizes innovative technology platforms to improve tissue-specific delivery and gene regulation, addressing key limitations of existing gene therapies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $72.8M
- Funding stage: M&A
- Last round: Series B (Aug 2024)
- Website: katetherapeutics.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/kate-therapeutics-36622 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.